Currently trading under a dime.
Read the recent Yahoo news.
Amarantus Diagnostic, the company's subsidiary, could be generating $300,000,000 in revenue within two years.
I think I will wait until they are removed from the pink sheets
100% upside by April 17.
Most undervalued bio-tech in the market.
Ive been watching that and failed to pull the trigger at .06 the other day. I missed the 29% upside on Friday.